Cargando…
Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study
OBJECTIVE: To assess the effect of HIV infection and combined antiretroviral therapy (c-ART) on various proatherogenic biomarkers and lipids and to investigate their relationship with subclinical atherosclerosis in a cohort of treatment-naive HIV-infected patients. METHODS: We performed a prospectiv...
Autores principales: | Di Yacovo, Silvana, Saumoy, Maria, Sánchez-Quesada, José Luís, Navarro, Antonio, Sviridov, Dmitri, Javaloyas, Manuel, Vila, Ramon, Vernet, Anton, Low, Hann, Peñafiel, Judith, García, Benito, Ordoñez-Llanos, Jordi, Podzamczer, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446923/ https://www.ncbi.nlm.nih.gov/pubmed/32817629 http://dx.doi.org/10.1371/journal.pone.0237739 |
Ejemplares similares
-
Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected Patients
por: Saumoy, Maria, et al.
Publicado: (2021) -
When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010) -
Immediate start of antiretroviral, why not?
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2018) -
HIV disease, metabolic dysfunction and atherosclerosis: A three year prospective study
por: Low, Hann, et al.
Publicado: (2019) -
Subclinical Hypothyroidism – Whether and When To Start Treatment?
por: Cojić, Milena, et al.
Publicado: (2017)